Issues: Vax Specific

Anthrax

Hepatitis B

Influenza

Lyme Disease
Meningococcal

MMR    

Polio

Rotavirus

● Smallpox

Tdap/Td

Varicella

Yellow Fever

 

Issues: Misc

Exemptions

Legislation 

New Vax Status

Thimerosal

Independent Vax  Safety Board

 

Vaccine Info

● 2009 Schedule

ACIP Recs

Components
IOM Reports

● Vax Injury Comp Program
Manufacturer Links

Package Inserts

Reporting AEs

Thimerosal Table

VAERS

VISs

 

Links
 

Search
 

About IVS

Faculty Biographies

Publications

Donations

 

Email IVS

 

Disclaimers & Privacy
 

 

Institute for Vaccine Safety

Johns Hopkins Bloomberg School of Public Health

615 N. Wolfe Street

Room W5041

Baltimore, MD 21205

www.vaccinesafety.edu

 

 

 

 

FirstPreviousNextLast
Dr. Halsey's presentation at the National Vaccine Advisory Committee Workshop on Thimerosal and Vaccines held in Bethesda, Maryland on August 11-12, 1999.

Slide 10 of 26
    Slide Notes:

    The smallest newborns can be less than half the weight of the largest newborns and this difference can continue until approximately 6 months of age. Guidelines should prevent potential harm from mercury exposure in this most vulnerable population, as pointed out by Kathryn R. Mahaffey, PhD, from the EPA. "If we take the weights of these children, and assume that they are receiving thimerosal-containing vaccines for each of the recommended vaccines by age, the following figure shows the dose of mercury in micrograms per kilogram that they would receive on the day vaccine is administered."